VRAX - Virax Biolabs Group Ltd

QQQ $ 620.08 $ -3.16 (-0.51 %)

DIA $ 470.45 $ 0.09 (0.02 %)

SPY $ 675.47 $ -0.66 (-0.1 %)

TLT $ 89.93 $ 0.14 (0.16 %)

GLD $ 361.93 $ -1.67 (-0.46 %)

Previous Close

$ 0.542

Open

$ 0.54

Bid

$ 0.51 x 700

Ask

$ 0.51 x 3,000

Day's Range

$ 0.51 - $ 0.53

52 Week Range

$ 0.52 - $ 3.20

Volume

854,557

Average Volume

Market Cap

2.35M

Beta (5Y Monthly)

$ 1.08

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type	Report Link
No Data found

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Virax Biolabs Completes Patient Recruitmen...
11/03/2025 13:32:08

Virax Biolabs Group Limited (NASDAQ:VRAX) ("Virax" or the "Company"), an innovative biotechnology company focus...

12 Health Care Stocks Moving In Monday's A...
09/08/2025 21:07:27

12 Health Care Stocks Moving In Tuesday's ...
08/26/2025 17:06:55

Virax Biolabs Received Nasdaq Noncomplianc...
07/18/2025 20:17:40

What's Driving the Market Sentiment Around...
06/30/2025 17:00:34

Virax Biolabs Group CFO Jason Davis To Res...
06/13/2025 20:30:29

-SEC Filing

World Health Organization Says MPOX Remain...
06/09/2025 14:22:11

https://www.who.int/news/item/09-06-2025-fourth-meeting-of-the-international-health-regulations-(2005)-emergency-committee-rega...

12-health-care-stocks-moving-in-mondays-pre-market-session

12 Health Care Stocks Moving In Monday's P...
04/14/2025 12:08:48

12-health-care-stocks-moving-in-fridays-after-market-session

12 Health Care Stocks Moving In Friday's A...
04/11/2025 21:06:36

virax-biolabs-investigational-diagnostic-tests-has-an-attractive-market-opportunity-analyst-initiates-with-buy-rating

Virax Biolabs' Investigational Diagnostic ...
03/31/2025 18:57:43

Virax Biolabs' T-cell testing platform targets post-viral syndromes like Long COVID. HC Wainwright sees a major market oppo...

HC Wainwright & Co. Initiates Coverage On ...
03/31/2025 11:00:01

HC Wainwright & Co. analyst Yi Chen initiates coverage on Virax Biolabs Group (NASDAQ:VRAX) with a Buy rating and announ...

Virax Biolabs Enrolls First Patients In It...
03/18/2025 11:30:53

"New Case Of Mpox Detected In The UK After...
01/27/2025 17:50:29

https://www.manchestereveningnews.co.uk/news/health/new-case-mpox-detected-uk-30876004 A new case of Mpox has been confirmed in...

Cosmos Health Entered Into A Supplemental ...
01/23/2025 20:39:13

Cosmos Health And Virax Biolabs Announce E...
01/13/2025 14:22:09

why-sangamo-therapeutics-shares-are-trading-higher-by-around-20-here-are-20-stocks-moving-premarket

Why Sangamo Therapeutics Shares Are Tradin...
12/19/2024 11:15:36

Virax Biolabs Announces 2025 Strategic Pri...
12/17/2024 12:49:22

Looking Ahead to 2025In 2025, our key priorities include:Advancing ViraxImmune™ UK and U.S. Clinical Validation Studies: We wil...

Virax Biolabs Partners With Tebubio To Bro...
12/10/2024 12:35:15

Companies will further integrate solutions that help utilities accelerate digitalization and tackle critical challenges such as...

World Health Organization Says Mpox Contin...
11/22/2024 17:43:12

https://worldhealthorg.shinyapps.io/mpx_global/

'UK detects two more cases of new mpox var...
11/04/2024 20:22:59

https://www.reuters.com/world/uk/uk-detects-two-more-cases-new-mpox-variant-2024-11-04/#:~:text=LONDON%2C%20Nov%204%20(Reuters)...